We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Medicaid Drug Rebate Program: HHS OIG Issues Report on Dispute Resolution Between Manufacturers and States

28 August 2014

Health, Pharmaceutical, and Biotechnology Alert

On Wednesday, August 20, 2014, the Office of Inspector General of the U.S. Department of Health & Human Services released a report discussing the extent to which rebates are disputed under the Medicaid drug rebate program and the causes of frequently occurring types of disputes.

Read More: Medicaid Drug Rebate Program: HHS OIG Issues Report on Dispute Resolution Between Manufacturers and States

The team

Loading data